Go Back

Company or ticker...

Genmab

Genmab develops antibody-based cancer medicines that help the immune system recognize and attack cancer cells.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

GMAB

32.5B

8.3

45.4

71.10%

Key Facts

M. Cap

PS

PE

YTD

32.5B

8.3

45.4

71.10%

10MA

20MA

50MA

200MA

$GMAB

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

Join Now

Join Now